Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at [email protected].

Home

sheeba farhat

Articles By : sheeba farhat

AstraZeneca Commits USD 405 Million to UK Life Sciences Amid Policy Shift

Written By sheeba farhat30 April 2026 6:13 PM IST

London: Prime Minister Keir Starmer said on Wednesday that Britain's biggest company AstraZeneca would invest 300 million pounds ($405 million) in...

Chiesi to Acquire KalVista for USD 1.9 Billion, Boosts Rare Disease Portfolio

Written By sheeba farhat30 April 2026 6:06 PM IST

Milan: Italian pharma company Chiesi Group will buy U.S.-listed KalVista Pharmaceuticals in an all-cash deal valued at about USD 1.9 billion, the two...

Dr. Reddy's Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply

Written By sheeba farhat29 April 2026 5:02 PM IST

New Delhi: OneSource Specialty Pharma Limited has announced that its partner Dr. Reddy's Laboratories Ltd. has received a Notice of Compliance from...

Serum Institute of India, University of Oxford Sign Licensing Pact for Multi-Stage Malaria Vaccine R78C

Written By sheeba farhat29 April 2026 3:53 PM IST

New Delhi: The University of Oxford and Serum Institute of India (SII) have hit a significant milestone in the global fight against malaria with a...

Pfizer Secures Vyndamax Patent Till 2031, Settles Disputes with Cipla, Hikma, Dexcel Pharma

Written By sheeba farhat29 April 2026 3:44 PM IST

Bengaluru: Pfizer said on Tuesday it has settled patent disputes with three generic drugmakers over its blockbuster heart drug Vyndamax, effectively...

Sun Pharma chairman calls Organon deal both happy and anxious moment

Dilip Shanghvi Calls Sun Pharma's USD 11.75 Billion Organon Deal "Exciting Yet Anxious" Amid Debt Push

Written By sheeba farhat28 April 2026 8:13 PM IST

New Delhi: Sun Pharmaceutical Industries' acquisition of US-based Organon & Co at USD 11.75 billion enterprise valuation is both a "happy" and...

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

Written By sheeba farhat28 April 2026 8:03 PM IST

Bengaluru: Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to USD2.3 billion in cash, as the U.S....

GSK's Efimosfermin Secures USFDA Breakthrough, EMA PRIME Tags for MASH

Written By sheeba farhat28 April 2026 7:54 PM IST

London: GlaxoSmithKline plc (GSK) has announced that its investigational liver therapy efimosfermin has received both Breakthrough Therapy Designation...

Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal

Written By sheeba farhat27 April 2026 12:50 PM IST

New Delhi: Sun Pharmaceutical Industries Limited and Organon & Co. has announced that they have entered into a definitive agreement under which...

Delhi Police Bust Illegal Pharma Drug Racket, Medical Representative Among 3 Held

Written By sheeba farhat27 April 2026 10:30 AM IST

New Delhi: Delhi Police has arrested three men for their alleged involvement in an illegal network supplying banned and controlled pharmaceutical...

Regeneron Secures USFDA Nod for First Gene Therapy Targeting Genetic Hearing Loss

Written By sheeba farhat26 April 2026 10:00 AM IST

New Delhi: The U.S. Food and Drug Administration (USFDA) has approved Regeneron's gene therapy ‌for a rare genetic form of deafness, the company said...

Pfizer Enters China's GLP-1 Market with Xianweiying Pre-Orders, Intensifies Weight-Loss Drug Race

Written By sheeba farhat26 April 2026 9:30 AM IST

New Delhi: Pfizer's GLP-1 weight management treatment Xianweiying is available for pre-order in China, a Reuters check on a local e-commerce...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok